Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Fatigue 1Depression 1Carcinoma, Non-Small-Cell Lung 1Anxiety Disorders 1Adenocarcinoma of Lung 1

Interventions

Psychiatric Rehabilitation 3Early Intervention, Educational 3Surveys and Questionnaires 2Methods 2Educational Status 2Cognitive Behavioral Therapy 2Yoga 1Uncertainty 1Standard of Care 1Qigong 1Psychosocial Intervention 1Practice Guidelines as Topic 1Mindfulness-Based Stress Reduction 1Meditation 1Interviews as Topic 1Gemcitabine 1Fluoxetine 1Exercise Therapy 1Counseling 1Cisplatin 1Caregivers 1Behavior Therapy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Fluoxetine × Thoracic × Clear all
NCT00005850 2016-07-04

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
21 enrolled
Thoracic

Adenocarcinoma of Lung, Anxiety Disorders, Carcinoma, Non-Small-Cell Lung, Depression, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡